Levetiracetam Injection (Iv) Suppliers & Bulk Manufacturers
Available Forms: Injection (IV)
Available Strengths: 100 mg/mL
Reference Brands: US: Keppra®, Keppra XR®; EU: Keppra®, Levetiracetam Teva®, EpiKeppra®, Zentiva®
Category:
Antipsychotropic Drugs
Levetiracetam IV acts by binding to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal activity. It is used for treating seizures, including partial-onset, myoclonic, and generalized tonic-clonic seizures. The IV form is ideal for acute seizure management when oral administration is not feasible.
Levetiracetam Injection (IV) is FDA-approved in the USA for the treatment of partial-onset, myoclonic, and generalized tonic-clonic seizures in various age groups when oral administration is not possible. It follows strict GMP standards and carries labeling requirements for CNS effects and neuropsychiatric warnings. In the European Union, Levetiracetam IV is approved through centralized or national procedures with emphasis on Risk Management Plans (RMPs) and Periodic Safety Update Reports (PSURs). It must demonstrate bioequivalence for generic versions. Explore high-quality Levetiracetam IV products and global B2B sourcing opportunities at Pharmatradz.com.
Levetiracetam Injection (IV) is available in Injection (IV)
and strengths such as 100 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Levetiracetam Injection (IV) is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Levetiracetam Injection (IV) can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Levetiracetam, marketed globally under brands like Keppra®, is a widely prescribed anticonvulsant used for treating epilepsy. Available in the US and EU, Levetiracetam comes in oral tablets (250 mg–1000 mg), oral solution (100 mg/mL), and injectable forms. This drug is effective in managing partial, generalized, and myoclonic seizures in adults and children. Its high tolerability and minimal drug interactions make it a preferred option among neurologists. Pharmatradz.com helps you connect with certified global B2B suppliers of Levetiracetam API, formulations, and bulk stock across regulated markets. Source top-quality Levetiracetam from audited manufacturers via Pharmatradz.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing